SOPHiA GENETICS Reports Second Quarter 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Morgan Stanley Downgrades Sophia Genetics SA (SOPH) to Equalweight, 'Macro Weighs On Qtr/Guide'
August 7, 2024 11:31 AM EDTMorgan Stanley analyst Tejas Savant downgraded Sophia Genetics SA (NASDAQ: SOPH) from Overweight to Equalweight with a price target of $5.00 (from $10.00).
The analyst comments "2Q miss on macro-related biopharma/EMEA headwinds; though leading indicators remain positive, guidance cut reflects achievable 2H ramp despite... More
SOPHiA GENETICS SA (SOPH) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY24 Revenue Guidance
August 6, 2024 6:51 AM EDTSOPHiA GENETICS SA (NASDAQ: SOPH) reported Q2 EPS of ($0.23), $0.03 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $16 million versus the consensus estimate of $17.4 million.
GUIDANCE:
SOPHiA GENETICS SA sees FY2024 revenue of $65-67 million, versus the... More
